Abstract
In this book chapter, we focus on application of genome annotation and analysis of microbes for synthetic biology and cancer biology research. We particularly emphasised on application of microbial genomics in synthetic biology and cancer biology. Finally, we delineated future perspective and potential route map for improving the microbial genome annotation and microbial genomics analysis. We infer that our future perspective strategies would assist in reshaping the genome annotation of microorganisms along with microbial genomics analysis. In addition, with better understanding on microbial genome annotation and microbial genomics analysis, we believe this would better enable synthetic biology and cancer biology applications.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM et al (2017) Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep 7:1834. https://doi.org/10.1038/s41598-017-02079-3
Ashburner M (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25:25–29. https://doi.org/10.1038/75556
Assaf R, Xia F, Stevens R (2020) Detecting operons in bacterial genomes via visual representation learning. bioRxiv 2020:860221. https://doi.org/10.1101/860221
Banerjee S, Wei Z, Tan F, Peck KN, Shih N, Feldman M et al (2015) Distinct microbiological signatures associated with triple negative breast cancer. Sci Rep 5:15162. https://doi.org/10.1038/srep15162
Berger I, Raj DBTG (2014) Improved baculoviral expression system and methods of producing the same. CA2898696A1. https://patents.google.com/patent/CA2898696A1/tr
Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M et al (1997) The complete genome sequence of Escherichia coli K-12. Science 277:1453–1462. https://doi.org/10.1126/science.277.5331.1453
Börnigen D, Ren B, Pickard R, Li J, Ozer E, Hartmann EM et al (2017) Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci Rep 7:17686. https://doi.org/10.1038/s41598-017-17795-z
Butler A, Hoffman P, Smibert P, Papalexi E, Satija R (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411–420. https://doi.org/10.1038/nbt.4096
Bzik DJ, Fox B, Fiering SN, Conejo-Garcia JR, Baird J, Sanders KL (2013) Method for treating cancer with Toxoplasma gondii vaccine. WO2013059411A1. https://patents.google.com/patent/WO2013059411A1/en
Cameron SJS, Lewis KE, Huws SA, Hegarty MJ, Lewis PD, Pachebat JA et al (2017) A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer. PLoS One 12:e0177062. https://doi.org/10.1371/journal.pone.0177062
Chattopadhyay I, Verma M, Panda M (2019) Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat 2019:18. https://doi.org/10.1177/1533033819867354
Cho M, Carter J, Harari S, Pei Z (2014) The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis. Clin Lab Med 34:699–710. https://doi.org/10.1016/j.cll.2014.08.002
Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G et al (2018) Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 67:1024–1032. https://doi.org/10.1136/gutjnl-2017-314281
Courbet A, Renard E, Molina F (2016) Bringing next-generation diagnostics to the clinic through synthetic biology. EMBO Mol Med 8:987–991. https://doi.org/10.15252/emmm.201606541
Danchin A, Ouzounis C, Tokuyasu T, Zucker J (2018) No wisdom in the crowd: genome annotation in the era of big data—current status and future prospects. Microb Biotechnol 11:588–605. https://doi.org/10.1111/1751-7915.13284
Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM et al (2018) Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67:120–127. https://doi.org/10.1136/gutjnl-2016-312580
FEBS-EMBO (2020) Concurrent session (lecture): CS III-6-3 SynBac: designer minimal baculovirus genome for drug discovery. In: ResearchGate [Internet]. https://www.researchgate.net/publication/265140755_FEBS-EMBO_Concurrent_Session_lecture_CS_III-6-3_SynBac_designer_minimal_baculovirus_genome_for_drug_discovery
Felgner S, Kocijancic D, Frahm M, Weiss S (2016) Bacteria in cancer therapy: renaissance of an old concept. Int J Microbiol 2016:e8451728. https://doi.org/10.1155/2016/8451728
Flemer B, Lynch DB, Brown JMR, Jeffery IB, Ryan FJ, Claesson MJ et al (2017) Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 66:633–643. https://doi.org/10.1136/gutjnl-2015-309595
Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R et al (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580–586. https://doi.org/10.1038/37551
Gao F, Zhang C-T (2008) Ori-Finder: a web-based system for finding oriCs in unannotated bacterial genomes. BMC Bioinfo 9:79. https://doi.org/10.1186/1471-2105-9-79
Garanina IA, Fisunov GY, Govorun VM (2018) BAC-BROWSER: the tool for visualization and analysis of prokaryotic genomes. Front Microbiol 9:2827. https://doi.org/10.3389/fmicb.2018.02827
Gene Ontology Consortium (2019) The gene Ontology resource: 20 years and still going strong. Nucleic Acids Res 47:D330–D338. https://doi.org/10.1093/nar/gky1055
Guerrero-Preston R, Godoy-Vitorino F, Jedlicka A, Rodríguez-Hilario A, González H, Bondy J et al (2016) 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget 7:51320–51334. https://doi.org/10.18632/oncotarget.9710
Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4:688–694. https://doi.org/10.1038/nrc1433
Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L et al (2018) Association of oral microbiome with risk for incident head and neck squamous cell cancer. JAMA Oncol 4:358–365. https://doi.org/10.1001/jamaoncol.2017.4777
Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ et al (2000) DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406:477–483. https://doi.org/10.1038/35020000
Hibberd AA, Lyra A, Ouwehand AC, Rolny P, Lindegren H, Cedgård L et al (2017) Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol 4:e000145. https://doi.org/10.1136/bmjgast-2017-000145
Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S et al (2016) The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 6:30751. https://doi.org/10.1038/srep30751
Hoffman RM (2012) The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages. Expert Opin Drug Discovery 7:73–83. https://doi.org/10.1517/17460441.2012.644534
Hood L, Rowen L (2013) The human genome project: big science transforms biology and medicine. Genome Med 5:79. https://doi.org/10.1186/gm483
Hyatt D, Chen G-L, LoCascio PF, Land ML, Larimer FW, Hauser LJ (2010) Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinfo 11:119. https://doi.org/10.1186/1471-2105-11-119
Inamura K (2020) Gut microbiota contributes towards immunomodulation against cancer: new frontiers in precision cancer therapeutics. Sem Cancer Biol 5:29. https://doi.org/10.1016/j.semcancer.2020.06.006
Jacob F, Monod J (1961) Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 3:318–356. https://doi.org/10.1016/S0022-2836(61)80072-7
Javed S, Mahmood A, Fraz MM, Koohbanani NA, Benes K, Tsang Y-W et al (2020) Cellular community detection for tissue phenotyping in colorectal cancer histology images. Med Image Anal 63:101696. https://doi.org/10.1016/j.media.2020.101696
Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B et al (2019) Commensal microbiota promote lung cancer development via γδ T cells. Cell 176:998–1013. https://doi.org/10.1016/j.cell.2018.12.040
Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH et al (2016) Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer 102:89–95. https://doi.org/10.1016/j.lungcan.2016.10.016
Lin C, Cai X, Zhang J, Wang W, Sheng Q, Hua H et al (2019) Role of gut microbiota in the development and treatment of colorectal Cancer. Digestion 100:72–78. https://doi.org/10.1159/000494052
Lomsadze A, Gemayel K, Tang S, Borodovsky M (2018) Modeling leaderless transcription and atypical genes results in more accurate gene prediction in prokaryotes. Genome Res 28:1079–1089. https://doi.org/10.1101/gr.230615.117
Loshitskiy PP, Nikolov NA (2015) Magnetothermia utilization in the curing of malignancies. Part 1. Radioelectron Commun Syst 58:49–60. https://doi.org/10.3103/S0735272715020016
Luo H, Gao F (2019) DoriC 10.0: an updated database of replication origins in prokaryotic genomes including chromosomes and plasmids. Nucleic Acids Res 47:D74–D77. https://doi.org/10.1093/nar/gky1014
Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M et al (2019) Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell 36:418–430. https://doi.org/10.1016/j.ccell.2019.08.007
Mackiewicz P, Zakrzewska-Czerwinska J, Zawilak A, Dudek MR, Cebrat S (2004) Where does bacterial replication start? Rules for predicting the oriC region. Nucleic Acids Res 32:3781–3791. https://doi.org/10.1093/nar/gkh699
Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM (2005) The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3:27. https://doi.org/10.1186/1479-5876-3-27
Meng W, Bai B, Sheng L, Li Y, Yue P, Li X et al (2015) Role of helicobacter pylori in gastric cancer: advances and controversies. Discov Med 20:285–293
Min J-J, Kim H-J, Park JH, Moon S, Jeong JH, Hong Y-J et al (2008) Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol 10:54–61. https://doi.org/10.1007/s11307-007-0120-5
Mulder NJ, Christoffels A, de Oliveira T, Gamieldien J, Hazelhurst S, Joubert F et al (2016) The development of computational biology in South Africa: successes achieved and lessons learnt. PLoS Comput Biol 12:e1004395. https://doi.org/10.1371/journal.pcbi.1004395
Nordor AV, Bellet D, Siwo GH (2018) Cancer–malaria: hidden connections. Open Biol 8:180127. https://doi.org/10.1098/rsob.180127
Özdemir V, Dove ES, Gürsoy UK, Şardaş S, Yıldırım A, Yılmaz ŞG et al (2017) Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome. J Neural Transm (Vienna) 124:25–32. https://doi.org/10.1007/s00702-015-1489-y
Payette PJ, Davis HL (2001) History of vaccines and positioning of current trends. Curr Drug Targets Infect Disord 1:241–247. https://doi.org/10.2174/1568005014606017
Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND et al (2017) Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res 77:6777–6787. https://doi.org/10.1158/0008-5472.CAN-17-1296
Raj TG, Balaji DB, Giliberto M, Cremaschi A, Skånland SS, Gade A, Tjønnfjord GE et al (2018a) Drug sensitivity screening on multiple myeloma for precision cancer therapy. Blood 132:4677–4677. https://doi.org/10.1182/blood-2018-99-110669
Raj TG, Balaji DB, Cremaschi A, Skånland SS, Gade A, Schjesvold FH, Tjønnfjord GE et al (2018b) In-vitro drug sensitivity screening in chronic lymphocytic leukemia (CLL) primary patient samples identifies drug candidates for precision cancer therapy. Blood 132:4676–4676. https://doi.org/10.1182/blood-2018-99-110357
Roberts NJ, Zhang L, Janku F, Collins A, Bai R-Y, Staedtke V et al (2014) Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6:249. https://doi.org/10.1126/scitranslmed.3008982
Rödelsperger C, Athanasouli M, Lenuzzi M, Theska T, Sun S, Dardiry M et al (2019) Crowdsourcing and the feasibility of manual gene annotation: a pilot study in the nematode Pristionchus pacificus. Sci Rep 9:18789. https://doi.org/10.1038/s41598-019-55359-5
Saus E, Iraola-Guzmán S, Willis JR, Brunet-Vega A, Gabaldón T (2019) Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential. Mol Asp Med 69:93–106. https://doi.org/10.1016/j.mam.2019.05.001
Seemann T (2014) Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. https://doi.org/10.1093/bioinformatics/btu153
Serra LM, Duncan WD, Diehl AD (2019) An ontology for representing hematologic malignancies: the cancer cell ontology. BMC Bioinfo 20:181. https://doi.org/10.1186/s12859-019-2722-8
Song M, Chan AT, Sun J (2020) Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology 158:322–340. https://doi.org/10.1053/j.gastro.2019.06.048
SynBac™ (2020) In: Geneva Biotech [cited 2 Nov 2020]. https://geneva-biotech.com/product_category/insect-cell-expression/synbac/
Taboada B, Estrada K, Ciria R, Merino E (2018) Operon-mapper: a web server for precise operon identification in bacterial and archaeal genomes. Bioinformatics 34:4118–4120. https://doi.org/10.1093/bioinformatics/bty496
Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP, Zaslavsky L et al (2016) NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res 44:6614–6624. https://doi.org/10.1093/nar/gkw569
Teif VB, Bohinc K (2011) Condensed DNA: condensing the concepts. Prog Biophys Mol Biol 105:208–222. https://doi.org/10.1016/j.pbiomolbio.2010.07.002
Tjaden B (2020) A computational system for identifying operons based on RNA-seq data. Methods 176:62–70. https://doi.org/10.1016/j.ymeth.2019.03.026
Trikudanathan G, Philip A, Dasanu CA, Baker WL (2011) Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 12:26–31
Tringe SG, von Mering C, Kobayashi A, Salamov AA, Chen K, Chang HW et al (2005) Comparative metagenomics of microbial communities. Science 308:554–557. https://doi.org/10.1126/science.1107851
Vijayachandran LS, Thimiri Govinda Raj DB, Edelweiss E, Gupta K, Maier J, Gordeliy V et al (2013) Gene gymnastics: synthetic biology for baculovirus expression vector system engineering. Bioengineered 4:279–287
Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S et al (2019) Gut microbiota and cancer: from pathogenesis to therapy. Cancer 11:38. https://doi.org/10.3390/cancers11010038
Wang H, Funchain P, Bebek G, Altemus J, Zhang H, Niazi F et al (2017) Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas. Genome Med 9:14. https://doi.org/10.1186/s13073-017-0405-5
White O, Eisen JA, Heidelberg JF, Hickey EK, Peterson JD, Dodson RJ et al (1999) Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science 286:1571–1577. https://doi.org/10.1126/science.286.5444.1571
Wintjens R, Bifani AM, Bifani P (2020) Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 spike protein. Vaccine 5:1–8. https://doi.org/10.1038/s41541-020-00237-9
Wood LM, Guirnalda PD, Seavey MM, Paterson Y (2008) Cancer immunotherapy using listeria monocytogenes and listerial virulence factors. Immunol Res 42:233–245. https://doi.org/10.1007/s12026-008-8087-0
Woodcroft BJ, Boyd JA, Tyson GW (2016) OrfM: a fast open reading frame predictor for metagenomic data. Bioinformatics 32:2702–2703. https://doi.org/10.1093/bioinformatics/btw241
Xu N, Wang L, Li C, Ding C, Li C, Fan W et al (2020) Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms. Transl Lung Cancer Res 9:1554–1568. https://doi.org/10.21037/tlcr-20-156
Xuan C, Shamonki JM, Chung A, Dinome ML, Chung M, Sieling PA et al (2014) Microbial dysbiosis is associated with human breast cancer. PLoS One 9:e83744. https://doi.org/10.1371/journal.pone.0083744
Yan X, Yang M, Liu J, Gao R, Hu J, Li J et al (2015) Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res 5:3111–3122
Yang J, Mu X, Wang Y, Zhu D, Zhang J, Liang C et al (2018) Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers. Front Oncol 8:520. https://doi.org/10.3389/fonc.2018.00520
Yang Y, Misra BB, Liang L, Bi D, Weng W, Wu W et al (2019a) Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer. Theranostics 9:4101–4114. https://doi.org/10.7150/thno.35186
Yang Y, Cai Q, Shu X-O, Steinwandel MD, Blot WJ, Zheng W et al (2019b) Prospective study of oral microbiome and colorectal cancer risk in low-income and African American populations. Int J Cancer 144:2381–2389. https://doi.org/10.1002/ijc.31941
Yao L, Jermanus C, Barbetta B, Choi C, Verbeke P, Ojcius DM et al (2010) Porphyromonas gingivalis infection sequesters pro-apoptotic bad through Akt in primary gingival epithelial cells. Mol Oral Microbiol 25:89–101. https://doi.org/10.1111/j.2041-1014.2010.00569.x
Youssef N, Budd A, Bielawski JP (2019) Introduction to genome biology and diversity. Methods Mol Biol 1910:3–31. https://doi.org/10.1007/978-1-4939-9074-0_1
Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y et al (2017) Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66:70–78. https://doi.org/10.1136/gutjnl-2015-309800
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Emmanuel Nweke, E., Suleman, E., Du Plessis, M., Thimiri Govinda Raj, D.B. (2021). Bioinformatics Tools for Gene and Genome Annotation Analysis of Microbes for Synthetic Biology and Cancer Biology Applications. In: Singh, V., Kumar, A. (eds) Advances in Bioinformatics. Springer, Singapore. https://doi.org/10.1007/978-981-33-6191-1_16
Download citation
DOI: https://doi.org/10.1007/978-981-33-6191-1_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6190-4
Online ISBN: 978-981-33-6191-1
eBook Packages: Computer ScienceComputer Science (R0)